Company Description
Medical Mari (OTC Link: MJNA) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.6M.
MJNA stock has declined 33.3% over the past year. Shares last traded at $0.0002.
This page provides a comprehensive overview of MJNA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Medical Mari (MJNA) stock last traded at $0.0002. Over the past 12 months, the stock has lost 33.3%. At a market capitalization of $2.6M, MJNA is classified as a micro-cap stock with approximately 10.0B shares outstanding.
Latest News
Medical Mari has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management, clinical trial, earnings. View all MJNA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Medical Mari (MJNA) currently stands at 20.0 thousand shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 86.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Medical Mari (MJNA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
MJNA Company Profile & Sector Positioning
Medical Mari (MJNA) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MJNA often look at related companies in the same sector, including Thc Biomed Intl (THCBF), Tilt Hldgs Inc (TLLTF), Blueberries Medi (BBRRF), Ctt Pharmaceutic (CTTH), and Body And Mind Inc (BMMJ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MJNA's relative position within its industry.